| Bioactivity | Adrixetinib is an inhibitor of protein tyrosine kinase with antineoplastic activity[1][2]. |
| Name | Adrixetinib |
| CAS | 2394874-66-7 |
| Formula | C25H24F3N5O5 |
| Molar Mass | 531.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. WHO Drug Informat ion - World Health Organization (WHO). [2]. Nam Kiyean, et al. Quinoline derivatives as inhibitors of Axl/Mer RTK and CSF1R and their preparation: World Intellectual Property Organization, WO2019229251. 2019-12-05. [3]. WHO Drug Information-World Health Organization (WHO). |